Cargando…
Beta Blocker Use After Acute Myocardial Infarction in the Patient with Normal Systolic Function: When is it “Ok” to Discontinue?
Beta-Blockers [BB] have been used extensively in the last 40 years after acute myocardial infarction [AMI] as part of therapy and in secondary prevention. The evidence for “routine” therapy with beta-blocker use post AMI rests largely on results of trials conducted over 25 years ago. However, there...
Autores principales: | Kezerashvili, Anna, Marzo, Kevin, Leon, Joshua De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394111/ https://www.ncbi.nlm.nih.gov/pubmed/22845818 http://dx.doi.org/10.2174/157340312801215764 |
Ejemplares similares
-
Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023) -
Implications of renin‐angiotensin‐system blocker discontinuation in acute decompensated heart failure with systolic dysfunction
por: Darden, Douglas, et al.
Publicado: (2019) -
Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
por: Giannakopoulos, Georgios, et al.
Publicado: (2021) -
Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
por: Joo, Seung-Jae
Publicado: (2023) -
Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)